Tata in talks to launch Moderna COVID-19 vaccine in India, reports

Updated : January 25, 2021 11:08 AM IST

Tata Medical & Diagnostics is said to have started initial discussions with Moderna Inc for a partnership to launch its COVID-19 vaccine in India.

Tata Medical & Diagnostics is said to have started initial discussions with Moderna Inc for a partnership to launch its COVID-19 vaccine in India, the Economic Times reported on Monday.

Tata could team up with India's Council of Scientific & Industrial Research (CSIR) to carry out clinical trials of Moderna's vaccine candidate in India, the report added, citing officials familiar with the matter.

This month, the Indian government gave emergency-use approval to a COVID-19 vaccine developed by Bharat Biotech International Ltd and state-run Indian Council of Medical Research, and another licensed from Oxford University and AstraZeneca PLC that is being manufactured by the Serum Institute of India.

Moderna did not respond to Reuters' request for comment outside business hours, while Tata Medical & Diagnostics did not immediately respond.

Tata in talks to launch Moderna COVID-19 vaccine in India, reports

You May Also Like

Gold rate today: Yellow metal falls below Rs 45,000 per 10 grams level; Silver declines 1%

First extension of Ram Janmabhoomi premises; trust purchases 7,285-sq.ft land for Rs 1 Cr

Legislation on H-1B visas introduced in US Congress

Trending on CNBC-TV18

recommended for you